OraSure Technologies Retained Earnings (Accumulated Deficit) 2010-2024 | OSUR
OraSure Technologies retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| OraSure Technologies Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-84 |
| 2022 | $-138 |
| 2021 | $-120 |
| 2020 | $-97 |
| 2019 | $-83 |
| 2018 | $-99 |
| 2017 | $-120 |
| 2016 | $-150 |
| 2015 | $-170 |
| 2014 | $-178 |
| 2013 | $-174 |
| 2012 | $-163 |
| 2011 | $-147 |
| 2010 | $-139 |
| 2009 | $-135 |
| OraSure Technologies Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-93 |
| 2024-06-30 | $-88 |
| 2024-03-31 | $-88 |
| 2023-12-31 | $-84 |
| 2023-09-30 | $-104 |
| 2023-06-30 | $-115 |
| 2023-03-31 | $-110 |
| 2022-12-31 | $-138 |
| 2022-09-30 | $-154 |
| 2022-06-30 | $-159 |
| 2022-03-31 | $-140 |
| 2021-12-31 | $-120 |
| 2021-09-30 | $-110 |
| 2021-06-30 | $-95 |
| 2021-03-31 | $-94 |
| 2020-12-31 | $-97 |
| 2020-09-30 | $-99 |
| 2020-06-30 | $-100 |
| 2020-03-31 | $-90 |
| 2019-12-31 | $-83 |
| 2019-09-30 | $-85 |
| 2019-06-30 | $-98 |
| 2019-03-31 | $-102 |
| 2018-12-31 | $-99 |
| 2018-09-30 | $-109 |
| 2018-06-30 | $-118 |
| 2018-03-31 | $-122 |
| 2017-12-31 | $-120 |
| 2017-09-30 | $-127 |
| 2017-06-30 | $-133 |
| 2017-03-31 | $-138 |
| 2016-12-31 | $-150 |
| 2016-09-30 | $-158 |
| 2016-06-30 | $-164 |
| 2016-03-31 | $-168 |
| 2015-12-31 | $-170 |
| 2015-09-30 | $-175 |
| 2015-06-30 | $-176 |
| 2015-03-31 | $-178 |
| 2014-12-31 | $-178 |
| 2014-09-30 | $-176 |
| 2014-06-30 | $-177 |
| 2014-03-31 | $-179 |
| 2013-12-31 | $-174 |
| 2013-09-30 | $-180 |
| 2013-06-30 | $-178 |
| 2013-03-31 | $-173 |
| 2012-12-31 | $-163 |
| 2012-09-30 | $-157 |
| 2012-06-30 | $-154 |
| 2012-03-31 | $-151 |
| 2011-12-31 | $-147 |
| 2011-09-30 | $-148 |
| 2011-06-30 | $-144 |
| 2011-03-31 | $-141 |
| 2010-12-31 | $-139 |
| 2010-09-30 | $-138 |
| 2010-06-30 | $-138 |
| 2010-03-31 | $-137 |
| 2009-12-31 | $-135 |
| 2009-09-30 | $-132 |
| 2009-06-30 | $-134 |
| 2009-03-31 | $-129 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.287B | $0.405B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.382B | 25.94 |
| Stryker (SYK) | United States | $148.728B | 33.52 |
| Boston Scientific (BSX) | United States | $134.855B | 38.77 |
| EssilorLuxottica (ESLOY) | France | $111.549B | 0.00 |
| Medtronic (MDT) | Ireland | $108.676B | 16.14 |
| Haleon (HLN) | United Kingdom | $43.230B | 28.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.368B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.464B | 19.43 |
| ResMed (RMD) | United States | $35.759B | 29.39 |
| Terumo (TRUMY) | Japan | $29.367B | 41.47 |
| Koninklijke Philips (PHG) | Netherlands | $24.796B | 18.98 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.580B | 13.74 |
| Insulet (PODD) | United States | $18.378B | 73.18 |
| Baxter (BAX) | United States | $16.844B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.947B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.886B | 39.63 |
| Bio-Rad Laboratories (BIO) | United States | $9.115B | 30.98 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.071B | 14.11 |
| TG Therapeutics (TGTX) | United States | $5.378B | 0.00 |
| Haemonetics (HAE) | United States | $4.291B | 20.94 |
| Prestige Consumer Healthcare (PBH) | United States | $4.157B | 20.67 |
| ICU Medical (ICUI) | United States | $4.134B | 39.36 |
| Perrigo (PRGO) | Ireland | $3.694B | 10.88 |
| Envista Holdings (NVST) | United States | $3.681B | 27.42 |
| Agios Pharmaceuticals (AGIO) | United States | $3.167B | 0.00 |
| Neogen (NEOG) | United States | $3.159B | 36.45 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.782B | 17.84 |
| QuidelOrtho (QDEL) | United States | $2.548B | 16.40 |
| LeMaitre Vascular (LMAT) | United States | $2.380B | 57.85 |
| Warby Parker (WRBY) | United States | $2.366B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.977B | 34.59 |
| AtriCure (ATRC) | United States | $1.740B | 0.00 |
| InMode (INMD) | Israel | $1.552B | 9.34 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.293B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.253B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.97 |
| Owens & Minor (OMI) | United States | $0.943B | 7.37 |
| National Vision Holdings (EYE) | United States | $0.910B | 30.40 |
| CeriBell (CBLL) | United States | $0.904B | 0.00 |
| Evolus (EOLS) | United States | $0.826B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.809B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.679B | 30.02 |
| Surmodics (SRDX) | United States | $0.561B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.561B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.554B | 0.00 |
| Quanterix (QTRX) | United States | $0.450B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.407B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.95 |
| Valneva SE (VALN) | France | $0.359B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.339B | 32.26 |
| Biote (BTMD) | United States | $0.334B | 7.31 |
| Sanara MedTech (SMTI) | United States | $0.326B | 0.00 |
| Cerus (CERS) | United States | $0.310B | 0.00 |
| Zynex (ZYXI) | United States | $0.258B | 54.07 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.219B | 15.12 |
| High Tide (HITI) | Canada | $0.215B | 89.00 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.189B | 2.67 |
| Jin Medical (ZJYL) | China | $0.166B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.164B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 98.40 |
| Zevia PBC (ZVIA) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.50 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.75 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 23.10 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.079B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.071B | 36.67 |
| Exagen (XGN) | United States | $0.069B | 0.00 |
| Modular Medical (MODD) | United States | $0.067B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| MariMed (MRMD) | United States | $0.059B | 0.00 |
| Safety Shot (SHOT) | United States | $0.053B | 0.00 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.033B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |